SE9302332D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9302332D0
SE9302332D0 SE19939302332A SE9302332A SE9302332D0 SE 9302332 D0 SE9302332 D0 SE 9302332D0 SE 19939302332 A SE19939302332 A SE 19939302332A SE 9302332 A SE9302332 A SE 9302332A SE 9302332 D0 SE9302332 D0 SE 9302332D0
Authority
SE
Sweden
Prior art keywords
pct
sec
date
new compounds
jul
Prior art date
Application number
SE19939302332A
Other languages
English (en)
Swedish (sv)
Inventor
Robin *Boar Bernard
John *Cross Alan
Alastair *Gray Duncan
Richard *Green Alfred
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE19939302332A priority Critical patent/SE9302332D0/xx
Publication of SE9302332D0 publication Critical patent/SE9302332D0/xx
Priority to IS4182A priority patent/IS4182A/is
Priority to ZA944569A priority patent/ZA944569B/xx
Priority to IL11015794A priority patent/IL110157A/xx
Priority to NZ268689A priority patent/NZ268689A/en
Priority to EP94921147A priority patent/EP0707584A1/en
Priority to US08/379,506 priority patent/US5731335A/en
Priority to AU71977/94A priority patent/AU691506B2/en
Priority to CA002164856A priority patent/CA2164856A1/en
Priority to PCT/SE1994/000663 priority patent/WO1995001979A1/en
Priority to JP7503998A priority patent/JPH08512312A/ja
Priority to MX9405110A priority patent/MX9405110A/es
Priority to SK1598-95A priority patent/SK159895A3/sk
Priority to SG1996005493A priority patent/SG64891A1/en
Priority to CZ9653A priority patent/CZ5396A3/cs
Priority to RU96103659A priority patent/RU2124011C1/ru
Priority to PL94312417A priority patent/PL176471B1/pl
Priority to BR9406923A priority patent/BR9406923A/pt
Priority to CN94192713A priority patent/CN1126994A/zh
Priority to HU9503744A priority patent/HUT75097A/hu
Priority to EG40594A priority patent/EG20569A/xx
Priority to EE9400387A priority patent/EE03193B1/xx
Priority to US08/459,847 priority patent/US5607956A/en
Priority to NO960028A priority patent/NO305955B1/no
Priority to FI960076A priority patent/FI960076A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE19939302332A 1993-07-06 1993-07-06 New compounds SE9302332D0 (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE19939302332A SE9302332D0 (sv) 1993-07-06 1993-07-06 New compounds
IS4182A IS4182A (is) 1993-07-06 1994-06-23 Nýjar (1-heteróasólýl-1-heterósýklýl) alkanafleiður og notkun þeirra við að vernda taugar
ZA944569A ZA944569B (en) 1993-07-06 1994-06-24 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
IL11015794A IL110157A (en) 1993-07-06 1994-06-29 (1-Heteroazolyl-1-heterocyclyl) alkane derivatives a process for their preparation and pharmaceutical compositions containing them
HU9503744A HUT75097A (en) 1993-07-06 1994-07-05 Novel (1-oxazolyl or thiazolyl-1-heterocyclyl) alkane and alkene derivatives further substituted by a heterocycle and their use for preparing neuroprotective agents
JP7503998A JPH08512312A (ja) 1993-07-06 1994-07-05 新規な（１−ヘテロアゾリル−１−ヘテロサイクリル）アルカン誘導体および神経保護剤としてのその使用
RU96103659A RU2124011C1 (ru) 1993-07-06 1994-07-05 Производное (1-гетероазолил-1-гетероциклил)алкана, или его геометрические или оптические изомеры или рацематы, или его фармацевтически приемлемые кислые соли присоединения, или его сольваты, способы его получения, ацилзамещенные соединения, фармацевтическая композиция, обладающая нейрозащитными свойствами
US08/379,506 US5731335A (en) 1993-07-06 1994-07-05 (1-Heteroazolyl-1-heterocycane derivatives and their use as neuroprotective agents
AU71977/94A AU691506B2 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
CA002164856A CA2164856A1 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
PCT/SE1994/000663 WO1995001979A1 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
NZ268689A NZ268689A (en) 1993-07-06 1994-07-05 Oxazole, thiazole and pyrazole derivatives and medicaments thereof
MX9405110A MX9405110A (es) 1993-07-06 1994-07-05 Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores.
SK1598-95A SK159895A3 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
SG1996005493A SG64891A1 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
CZ9653A CZ5396A3 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkanes process of their preparation, intermediates for their preparation and pharmaceutical compositions containing thereof
EP94921147A EP0707584A1 (en) 1993-07-06 1994-07-05 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
PL94312417A PL176471B1 (pl) 1993-07-06 1994-07-05 Nowe pochodne (1-heteroazolilo-1-heterocyklo)alkanów, sposób ich wytwarzania i kompozycja farmaceutyczna je zawierająca
BR9406923A BR9406923A (pt) 1993-07-06 1994-07-05 Compostos derivados de (1-heteroazolil-1-heterociclil)alcano processo para preparar os mesmos formulaçao farmaceutica uso de compostos e processo para o tratamento de disturbios neuropsiquiatricos cronicos e agudos
CN94192713A CN1126994A (zh) 1993-07-06 1994-07-05 新的(1-杂唑基-1-杂环基)烷烃衍生物及其作为神经保护剂所用途
EG40594A EG20569A (en) 1993-07-06 1994-07-06 Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents
EE9400387A EE03193B1 (et) 1993-07-06 1994-11-23 (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks
US08/459,847 US5607956A (en) 1993-07-06 1995-06-02 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents
NO960028A NO305955B1 (no) 1993-07-06 1996-01-04 Nye (1-heteroazolyl-1-heterocyklyl)alkanderivater, mellomprodukter for deres fremstilling, farmasoeytisk preparat inneholdende slike derivater, og deres anvendelse til fremstilling av neurobeskyttende midler
FI960076A FI960076A (fi) 1993-07-06 1996-01-08 Uudet (1-heteroatsolyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302332A SE9302332D0 (sv) 1993-07-06 1993-07-06 New compounds

Publications (1)

Publication Number Publication Date
SE9302332D0 true SE9302332D0 (sv) 1993-07-06

Family

ID=20390539

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939302332A SE9302332D0 (sv) 1993-07-06 1993-07-06 New compounds

Country Status (24)

Country Link
US (2) US5731335A (ru)
EP (1) EP0707584A1 (ru)
JP (1) JPH08512312A (ru)
CN (1) CN1126994A (ru)
AU (1) AU691506B2 (ru)
BR (1) BR9406923A (ru)
CA (1) CA2164856A1 (ru)
CZ (1) CZ5396A3 (ru)
EE (1) EE03193B1 (ru)
EG (1) EG20569A (ru)
FI (1) FI960076A (ru)
HU (1) HUT75097A (ru)
IL (1) IL110157A (ru)
IS (1) IS4182A (ru)
MX (1) MX9405110A (ru)
NO (1) NO305955B1 (ru)
NZ (1) NZ268689A (ru)
PL (1) PL176471B1 (ru)
RU (1) RU2124011C1 (ru)
SE (1) SE9302332D0 (ru)
SG (1) SG64891A1 (ru)
SK (1) SK159895A3 (ru)
WO (1) WO1995001979A1 (ru)
ZA (1) ZA944569B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE19645313A1 (de) 1996-11-04 1998-05-07 Basf Ag Substituierte 3-Benzylpyrazole
CA2311125C (en) 1997-11-19 2011-01-18 Takeda Chemical Industries, Ltd. Apoptosis inhibitor
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
AU4589701A (en) 2000-03-24 2001-10-08 Cocensys Inc Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
BRPI0506749A (pt) 2004-01-12 2007-05-22 Applied Research Systems derivados de tiazol e uso dos mesmos
EP1794167A4 (en) * 2004-09-10 2009-10-21 Syngenta Ltd SUBSTITUTED ISOXAZOLE AS FUNGICIDES
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101711242B (zh) * 2007-05-23 2013-09-25 阿勒根公司 作为肾上腺素能受体激动剂的((二环杂芳基)咪唑基)甲基杂芳基化合物
WO2009123164A1 (ja) * 2008-04-02 2009-10-08 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体
WO2012010567A1 (en) * 2010-07-19 2012-01-26 Syngenta Participations Ag Isoxazole, isothiazole, furane and thiophene compounds as microbicides
EP2447261A1 (en) * 2010-10-29 2012-05-02 Basf Se Pyrrole, furane and thiophene derivatives and their use as fungicides
JP2014525442A (ja) * 2011-08-30 2014-09-29 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
US5068237A (en) * 1990-05-21 1991-11-26 Warner-Lambert Company Substituted furans and derivatives thereof acting at muscarinic receptors
AU3171493A (en) * 1991-12-31 1993-07-28 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Also Published As

Publication number Publication date
FI960076A0 (fi) 1996-01-08
NO305955B1 (no) 1999-08-23
ZA944569B (en) 1995-02-15
WO1995001979A1 (en) 1995-01-19
AU7197794A (en) 1995-02-06
HU9503744D0 (en) 1996-02-28
FI960076A (fi) 1996-01-08
IL110157A0 (en) 1994-10-07
SK159895A3 (en) 1996-09-04
IS4182A (is) 1995-01-07
AU691506B2 (en) 1998-05-21
SG64891A1 (en) 1999-05-25
US5731335A (en) 1998-03-24
NO960028L (no) 1996-02-27
PL176471B1 (pl) 1999-06-30
MX9405110A (es) 1995-01-31
HUT75097A (en) 1997-04-28
RU2124011C1 (ru) 1998-12-27
CZ5396A3 (en) 1996-06-12
NZ268689A (en) 1997-11-24
CA2164856A1 (en) 1995-01-19
NO960028D0 (no) 1996-01-04
EE03193B1 (et) 1999-06-15
JPH08512312A (ja) 1996-12-24
BR9406923A (pt) 1996-07-30
CN1126994A (zh) 1996-07-17
PL312417A1 (en) 1996-04-15
IL110157A (en) 2000-01-31
US5607956A (en) 1997-03-04
EG20569A (en) 1999-08-30
EP0707584A1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
FI970148A (fi) Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina
NO970162D0 (no) Substituerte pyrimidinforbindelser og anvendelse derav
SE9302332D0 (sv) New compounds
ES2085651T3 (es) Inhibidores no peptidicos de integrina que presentan especificidad para el receptor gpiibiiia.
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
FI970149A0 (fi) Tiatsoli- ja tiadiatsoliyhdisteiden käyttö D3-reseptoriligandeina
MY135841A (en) Novel benzodioxoles
MXPA04001891A (es) Inhibidores policiclicos de guanina fosfodiesterasa v.
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
SE9703414D0 (sv) New compounds
ES2530972T3 (es) Métodos de tratamiento de trastornos
ATE251153T1 (de) Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung
ATE153665T1 (de) Tricyclische inhibitoren von gp ii b iii a rezeptoren
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
SG147472A1 (en) N-thiazol-2-yl-benzamide derivatives
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
BG105710A (en) 5ht1 antagonists for antidepressant therapy
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
DE602004010186D1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2